Pillstats
OTC · Tablet, Extended Release · Oral

Pseudoephedrine Hydrochloride

Brands: Nasal Decongestant · Pseudoephedrine Hydrochloride

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US7 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)8896
US makers6 labelers
Packages8
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.082$0.165$0.247$0.330Dec 2025Apr 2026Jul 2026
$0.285
Latest avg · Jul 22, 2026
+8%
Since Dec 17, 2025
6
Active US suppliers
50%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

Only one quarter on record so far — the trend line fills in as more quarters load.

12
Rx · 2025 Q1
182
Units dispensed
1
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Strategic Sourcing Services LLCunknown2SUPPLYING
Aurohealth LLCunknown2SUPPLYING
HEBunknown1SUPPLYING
OHM LABORATORIES INCunknown1SUPPLYING
Discount Drug Martunknown1SUPPLYING
WALGREEN COMPANYunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.